Tambiciclib (SLS009), a novel, potent CDK9 inhibitor is effective in killing ASXL1 mutated and TP53 knockout Acute Myeloid Leukemia cell lines
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Elizabeth Trull, Philip Amrein
Institution: Massachusetts General Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417019059
Cites:
Cited by:
Related to: